TOHEAL PHARMA | BLUE PEARL TEXSPIN | TOHEAL PHARMA/ BLUE PEARL TEXSPIN |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -547.6 | 566.1 | - | View Chart |
P/BV | x | 14.5 | - | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
TOHEAL PHARMA BLUE PEARL TEXSPIN |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
TOHEAL PHARMA Mar-23 |
BLUE PEARL TEXSPIN Mar-23 |
TOHEAL PHARMA/ BLUE PEARL TEXSPIN |
5-Yr Chart Click to enlarge
|
||
High | Rs | 33 | 36 | 92.7% | |
Low | Rs | 5 | 25 | 20.6% | |
Sales per share (Unadj.) | Rs | 0.1 | 8.6 | 1.2% | |
Earnings per share (Unadj.) | Rs | 0 | -0.3 | -4.3% | |
Cash flow per share (Unadj.) | Rs | 0 | -0.3 | -6.3% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 7.2 | -4.5 | -160.3% | |
Shares outstanding (eoy) | m | 9.48 | 0.26 | 3,646.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 184.5 | 3.5 | 5,284.6% | |
Avg P/E ratio | x | 1,607.1 | -107.6 | -1,493.3% | |
P/CF ratio (eoy) | x | 1,166.4 | -107.6 | -1,083.8% | |
Price / Book Value ratio | x | 2.7 | -6.7 | -39.7% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 181 | 8 | 2,317.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 0 | 0 | 200.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1 | 2 | 43.9% | |
Other income | Rs m | 1 | 0 | - | |
Total revenues | Rs m | 1 | 2 | 66.8% | |
Gross profit | Rs m | 0 | 0 | 400.0% | |
Depreciation | Rs m | 0 | 0 | - | |
Interest | Rs m | 0 | 0 | - | |
Profit before tax | Rs m | 0 | 0 | -214.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 0 | - | |
Profit after tax | Rs m | 0 | 0 | -157.1% | |
Gross profit margin | % | -28.7 | -3.2 | 893.0% | |
Effective tax rate | % | 25.3 | 0 | - | |
Net profit margin | % | 11.4 | -3.2 | -355.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 58 | 2 | 3,384.9% | |
Current liabilities | Rs m | 0 | 3 | 4.8% | |
Net working cap to sales | % | 5,925.8 | -62.4 | -9,489.8% | |
Current ratio | x | 388.1 | 0.6 | 70,179.9% | |
Inventory Days | Days | 3,330 | 35 | 9,640.6% | |
Debtors Days | Days | 2,708 | 1,348,184 | 0.2% | |
Net fixed assets | Rs m | 10 | 0 | 4,282.6% | |
Share capital | Rs m | 95 | 3 | 3,703.5% | |
"Free" reserves | Rs m | -27 | -4 | 726.3% | |
Net worth | Rs m | 68 | -1 | -5,844.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 68 | 2 | 3,509.3% | |
Interest coverage | x | 4.8 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0 | 1.1 | 1.3% | |
Return on assets | % | 0.2 | -3.7 | -5.9% | |
Return on equity | % | 0.2 | 6.2 | 2.7% | |
Return on capital | % | 0.3 | 6.2 | 4.4% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1 | 0 | 187.0% | |
From Investments | Rs m | NA | NA | - | |
From Financial Activity | Rs m | NA | 1 | 0.0% | |
Net Cashflow | Rs m | -1 | 0 | -2,150.0% |
Indian Promoters | % | 3.9 | 0.1 | 3,007.7% | |
Foreign collaborators | % | 0.0 | 19.5 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 96.1 | 80.3 | 119.6% | |
Shareholders | 1,070 | 8,401 | 12.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare TOHEAL PHARMA With: ADANI ENTERPRISES MMTC REDINGTON SIRCA PAINTS INDIA NOVARTIS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | TOHEAL PHARM | E-WHA FOAM (I) | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.01% | 0.00% | 0.45% |
1-Month | 29.83% | 4.98% | 2.55% |
1-Year | 480.46% | 25.40% | 56.14% |
3-Year CAGR | 241.31% | 59.11% | 15.22% |
5-Year CAGR | 138.13% | 27.07% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the TOHEAL PHARM share price and the E-WHA FOAM (I) share price.
Moving on to shareholding structures...
The promoters of TOHEAL PHARM hold a 3.9% stake in the company. In case of E-WHA FOAM (I) the stake stands at 19.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of TOHEAL PHARM and the shareholding pattern of E-WHA FOAM (I).
Finally, a word on dividends...
In the most recent financial year, TOHEAL PHARM paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
E-WHA FOAM (I) paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of TOHEAL PHARM, and the dividend history of E-WHA FOAM (I).
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.